Swedish life sciences-focused VC Karolinska Development has sold its majority interest in pharmaceuticals startup XSpray Microparticles to a consortium led by Östersjöstiftelsen and Recipharm Venture Fund.
UCL Technology Fund closed on £50m in January 2016 and is now fully deployed
All five lawyers have joined from Clifford Chance and will focus on mandates for private equity firms
Deal is part of a buy-and-build strategy pursued by the GP to strengthen Italcanditi's market position
Tavola already owns Frische und Service's Swiss market peer Ceposa, which it acquired in 2018